Compounds of formula (I)
##STR1##
and pharmaceutically acceptable derivatives thereof bind with high affinity to
the EP4 receptor and are of use in the treatment or prevention of conditions such
as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
